These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11267167)

  • 1. Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine.
    Ponticelli C; Yussim A; Cambi V; Legendre C; Rizzo G; Salvadori M; Kahn D; Kashi SH; Salmela K; Fricke L; Garcia-Martinez J; Lechler R; Heemann U; Monteon F; Ortuño J; Amenabar JJ; Arias M; Nicholson ML; Sperschneider H; Abendroth D; Gracida C; Lao M; Sever MS; Lameire N; Sanchez-Fructuoso A; Bascì A; Segoloni G; Connolly J; Altieri P; Akoh J; Prestele H; Girault D
    Transplant Proc; 2001; 33(1-2):1009-10. PubMed ID: 11267167
    [No Abstract]   [Full Text] [Related]  

  • 2. Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.
    Folkmane I; Bicans J; Amerika D; Chapenko S; Murovska M; Rosentals R
    Transplant Proc; 2001; 33(7-8):3209-10. PubMed ID: 11750377
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing acute rejection with basiliximab and triple immunosuppression after renal transplantation.
    Kandus A
    Transplant Proc; 2002 Nov; 34(7):2907-9. PubMed ID: 12431653
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months.
    Kandus A; Kovac D; Buturović-Ponikvar J; Ponikvar R; Koselj M; Lindic J; Kmetec A; Bren AF
    Transplant Proc; 2001; 33(7-8):3207-8. PubMed ID: 11750376
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.
    Ponticelli C; Yussim A; Cambi V; Legendre C; Rizzo G; Salvadori M; Kahn D; Kashi H; Salmela K; Fricke L; Heemann U; Garcia-Martinez J; Lechler R; Prestele H; Girault D;
    Transplantation; 2001 Oct; 72(7):1261-7. PubMed ID: 11602853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early experience with simulect (basiliximab) induction in living donor renal allografting in India.
    Siwach V; Dhanda R; Aggarwal B; Singh B; Jain PK; Sarin PK
    Transplant Proc; 2003 Feb; 35(1):196-7. PubMed ID: 12591364
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients.
    Vester U; Kranz B; Testa G; Malagò M; Beelen D; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2001 Aug; 5(4):297-301. PubMed ID: 11472610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of renal transplantation with different immunosuppressive regimens.
    Folkmane I; Bicans J; Chapenko S; Murovska M; Rosentals R
    Transplant Proc; 2002 Mar; 34(2):558-9. PubMed ID: 12009623
    [No Abstract]   [Full Text] [Related]  

  • 10. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
    Kovac D; Kotnik V; Kandus A
    Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimarães S
    Transplant Proc; 2000 Dec; 32(8):2623-5. PubMed ID: 11134730
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic analysis of basiliximab in renal transplantation.
    Keown PA; Balshaw R; Krueger H; Baladi JF
    Transplantation; 2001 Jun; 71(11):1573-9. PubMed ID: 11435967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
    Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basiliximab: efficacy and tolerability in adults and children.
    Mocarquer A; Pinto V; Buckel E; Lagos E; Pefaur J; Ramirez K; Morales J; Rosatti P; Elberg A;
    Transplant Proc; 2003 Nov; 35(7):2518-9. PubMed ID: 14612000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients.
    Shah MH; Bokhari MZ; Bokhari MT; Farooq A; Yousaf SM
    Transplant Proc; 2003 Nov; 35(7):2737-8. PubMed ID: 14612099
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients.
    Offner G; Broyer M; Niaudet P; Loirat C; Mentser M; Lemire J; Crocker JF; Cochat P; Clark G; Chodoff L; Korn A; Hall M
    Transplantation; 2002 Oct; 74(7):961-6. PubMed ID: 12394837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.
    Vincenti F; Monaco A; Grinyo J; Kinkhabwala M; Neylan J; Roza A; Somberg K
    Transplant Proc; 2001; 33(1-2):1011-2. PubMed ID: 11267168
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.
    Keown P; Balshaw R; Khorasheh S; Chong M; Marra C; Kalo Z; Korn A
    BioDrugs; 2003; 17(4):271-9. PubMed ID: 12899644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2R antagonists in the prevention of acute rejection in living donor transplantation.
    Ivanovski N; Popov Z; Kolevski P; Cakalaroski K; Spasovski G; Sikole A; Paneva-Masin J
    Transplant Proc; 2001; 33(7-8):3203-4. PubMed ID: 11750374
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression.
    Boletis JN; Theodoropoulou H; Hiras T; Stamatiadis D; Darema M; Psimenou E; Stathakis C; Kostakis A
    Transplant Proc; 2001; 33(7-8):3184-6. PubMed ID: 11750366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.